1
Reid W von Borstel: Compositions and methods for treatment of mitochondrial diseases. Pro Neuron, Nixon & Vanderhye, October 29, 2002: US06472378 (43 worldwide citation)

Compounds, compositions, and methods are provided for treatment of disorders related to mitochondrial dysfunction. The methods comprise administering to a mammal a composition containing pyrimidine nucleotide precursors in amounts sufficient to treat symptoms resulting from mitochondrial respiratory ...


2
Shalini Sharma, Reid W von Borstel: Compounds for the treatment of metabolic disorders. Wellstat Therapeutics Corporation, Lewis J Kreisler, August 2, 2005: US06924314 (40 worldwide citation)

Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.


3
Shalini Sharma, Reid W von Borstel: Compounds for the treatment of metabolic disorders. Wellstat Therapeutics Corporation, Lewis J Kreisler, March 14, 2006: US07012071 (31 worldwide citation)

Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.


4
Reid W von Borstel, Michael K Bamat: Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides. Pro Neuron, Nixon & Vanderhye, April 7, 1998: US05736531 (31 worldwide citation)

The subject invention discloses compounds, compositions and methods for treatment and prevention of toxicity due to chemotherapeutic agents and antiviral agents. Disclosed are acylated derivatives of non-methylated pyrimidine nucleosides. These compounds are capable of attenuating damage to the hema ...


5
Shalini Sharma, Reid W von Borstel: Compounds for the treatment of metabolic disorders. Wellstat Therapeutics Corporation, Lewis J Kreisler, September 5, 2006: US07101910 (30 worldwide citation)

Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.


6
Shalini Sharma, Reid W von Borstel: Compounds for the treatment of metabolic disorders. Wellstat Therapeutics Corporation, Lewis J Kreisler, September 20, 2005: US06946491 (29 worldwide citation)

Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.


7
Shalini Sharma, Reid W von Borstel: Compounds for the treatment of metabolic disorders. Wellstat Therapeutics Corporation, Lewis J Kreisler, February 22, 2005: US06858602 (29 worldwide citation)

Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.


8
Reid W von Borstel, Michael K Bamat, Bradley M Hiltbrand: Acylated pyrimidine nucleosides for treatment of systemic inflammation and inflammatory hepatitis. Pro Neuron, Nixon & Vanderhye P C, November 25, 1997: US05691320 (27 worldwide citation)

Pyrimidine nucleotide precursors including acyl derivatives of cytidine, uridine, and orotate, and uridine phosphorylase inhibitors, and their use in enhancing resistance to sepsis or systemic inflammation are disclosed.


9
Jeffrey A Heroux, George B Sigal, Reid W von Borstel: Assays for measuring nucleic acid damaging activities. IGEN International, Nixon & Vanderhye P C, April 10, 2001: US06214552 (22 worldwide citation)

A method for assaying a sample for a nucleic acid damaging activity using at least one singular double-stranded nucleic acid with at least one electrochemiluminescent label, and a method for measuring an inhibitor of a nucleic acid damaging activity with at least one singular double-stranded nucleic ...


10
Reid W von Borstel, Michael K Bamat: Methods for promoting wound healing with deoxyribonucleosides. Pro Neuron, Nixon & Vanderhye, September 21, 1993: US05246708 (20 worldwide citation)

Methods are provided for promoting wound healing in animals by administering compositions containing two or more of the following 2'-deoxyribonucleosides: 2'-deoxyadenosine, 2'-deoxyguanosine, 2'-deoxy-cytidine, or thymidine. 3'- and 5'-phosphate derivatives of these 2'-deoxynucleosides are also eff ...